
David W. Dodington/researchgate.net
Nov 18, 2024, 18:00
Common problem in GI oncology – NED in Non-Neuroendocrine Carcinoma
Thor Halfdanarson, Professor of Oncology at Mayo Clinic, shared an article by David W. Dodington on X:
“Here is a common problem in GI oncology, neuroendocrine differentiation (NED) in non-neuroendocrine carcinoma.
According to many studies, outcomes are worse if NED is present (colorectum, esophagus, stomach, lung and more).
I get asked this often…”
Authors: David W. Dodington, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 02:44
Feb 22, 2025, 02:36
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13